In summary, this study found that the FYB1-CAPG axis may regulates the PI3K/AKT/mTOR signaling pathway, thereby affecting the survival of AML cells, and FYB1-CAPG axis is a new target we have discovered. The gene discussed is AKT1; the disease is acute myeloid leukemia.